Grants per year
Search results
-
Active
Prot #CAB-201-002: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Idiopathic Inflammatory Myopathy
Georges, G. E. (PD/PI)
Advanced Clinical LLC, Cabaletta Bio, Inc.
7/10/24 → 7/10/27
Project: Research project
-
Prot #CYTB323L12201: A Phase 2, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants with Severe Refractory Idiopathic Inflammatory Myopathies
Georges, G. E. (PD/PI)
Novartis Pharmaceuticals Corporation
7/1/24 → 8/1/32
Project: Research project
-
Prot #CYTB323K12201: A Phase II, Multi-Part, Three-Year, Randomized, Open-Label, Assessor-Blinded, Active-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Rituximab Treatment in Participants with Severe R
Georges, G. E. (PD/PI)
Novartis Pharmaceuticals Corporation
4/10/24 → 3/31/30
Project: Research project
-
Prot #CAB-201-003: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Systemic Sclerosis
Georges, G. E. (PD/PI), Georges, G. E. (PD/PI) & Richardson, C. L. (Co-Investigator)
Advanced Clinical LLC, Cabaletta Bio, Inc.
4/1/24 → 9/13/27
Project: Research project
-
Prot #CYTB323J12201: A Phase 2, Adaptive, Randomized, Open-Label, Assessor-Blinded Active-Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Standard of Care in Patients Suffering from Systemic Lupus Erythematosus (SL
Georges, G. E. (PD/PI)
Novartis Pharmaceuticals Corporation
3/19/24 → 12/31/30
Project: Research project
-
A Multicenter Randomized Controlled Trial of High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Stem Cell Transplant versus Best Available Approved Therapy for Treatment-Resistant Relapsing Multiple Sclerosis - Fixed Rate
Georges, G. E. (PD/PI) & Cohen, B. A. (Co-Investigator)
Benaroya Research Institute at Virginia Mason, National Institute of Allergy and Infectious Diseases
2/1/24 → 1/31/28
Project: Research project
-
Immune Tolerance Network
Georges, G. E. (PD/PI)
Benaroya Research Institute at Virginia Mason, National Institute of Allergy and Infectious Diseases
6/1/23 → 1/31/28
Project: Research project
-
Finished
Prot #CAB-201-002: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Idiopathic Inflammatory Myopathy
Georges, G. E. (PD/PI), Hsieh, C. (PD/PI) & Hsieh, C. (Co-Investigator)
Advanced Clinical LLC, Cabaletta Bio, Inc.
1/22/24 → 5/21/24
Project: Research project